Cellectar Biosciences raises $2.5M via warrant exercise inducement at $0.3041/share

Cellectar Biosciences, Inc.

Gross proceeds ~$2.5M from immediate exercise of 8,301,322 outstanding warrants at $0.3041/share.
Warrants originally issued on June 5, 2020, Oct 25, 2022, and July 21, 2024; no replacement warrants issued.
Closing expected on or about June 6, 2025; Ladenburg Thalmann acting as exclusive placement agent.
Net proceeds for general corporate purposes including working capital and operating expenses.
All shares underlying the warrants are registered or resale-registered with the SEC.

item 1.01item 3.02item 3.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.